Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK)

Price 1,427.40p on 02-02-2023 at 18:28:02
Change 7.80p 0.55%
Buy 1,433.80p
Sell 1,433.20p
Buy / Sell GSK Shares
Last Trade: Unknown 48,000.00 at 1,424.63p
Day's Volume: 12,350,339
Last Close: 1,427.40p
Open: 1,425.00p
ISIN: GB00BN7SWP63
Day's Range 1,407.40p - 1,437.20p
52wk Range: 1,283.20p - 1,824.40p
Market Capitalisation: £58,441m
VWAP: 1,423.29423p
Shares in Issue: 4,094m

Recent Trades History Glaxosmithkline (GSK)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 48,000 1,424.63p Ordinary
Currency Conversion
18:28:02 - 02-Feb-23
Unknown* 710 1,409.997p Ordinary
Currency Conversion
OTC Trade
18:10:40 - 02-Feb-23
Unknown* 5,846 1,427.998p Ordinary
Currency Conversion
OTC Trade
18:07:05 - 02-Feb-23
Unknown* 20 1,427.40p Ordinary
Currency Conversion
OTC Trade
18:06:17 - 02-Feb-23
Unknown* 5,912 1,427.40p Ordinary
Currency Conversion
OTC Trade
18:05:26 - 02-Feb-23
Unknown* 547 1,424.864p Ordinary
Currency Conversion
OTC Trade
18:02:51 - 02-Feb-23
Unknown* 5,491 1,429.996p Ordinary
Currency Conversion
OTC Trade
18:02:51 - 02-Feb-23
Unknown* 102 1,424.917p Ordinary
Currency Conversion
OTC Trade
18:02:51 - 02-Feb-23
Unknown* 63 1,429.765p Ordinary
Currency Conversion
OTC Trade
18:02:51 - 02-Feb-23
Unknown* 312 1,429.706p Ordinary
Currency Conversion
OTC Trade
18:02:51 - 02-Feb-23

Share Price History for Glaxosmithkline

Time period:
to
Date Open High Low Close Volume

Share News for Glaxosmithkline

GSK gets FDA approval for drug to treat anaemia in adults on dialysis

2nd Feb 2023 09:26

(Alliance News) - GSK PLC on Thursday said its Jesduvroq drug has been approved by the US Food & Drug Administration for anaemia of chronic kidney disease in adults on dialysis. Read More

LONDON BROKER RATINGS: Goldman Sachs cuts Standard Chartered

2nd Feb 2023 09:19

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

LONDON MARKET OPEN: GSK profit up; Vodafone growth slows; US Fed ahead

1st Feb 2023 09:13

(Alliance News) - Stock prices in London opened higher on Wednesday, as investors expect to see the US central bank continue to slow the pace of its interest rate hikes. Read More

TOP NEWS: GSK profit grows as aims for first-ever approved RSV vaccine

1st Feb 2023 09:09

(Alliance News) - GSK PLC on Wednesday reported a growth in profit and revenue for 2022 as it looks towards a possible spate of drug approvals for 2023. Read More

CORRECT: Stocks open higher ahead of US Fed rate decision

1st Feb 2023 08:03

(Correcting 2021 comparison figure for GSK revenue.) Read More

FTSE 100 Latest
Value7,820.16
Change59.05

Login to your account

Forgot Password?

Not Registered